Moolec Science SA (NASDAQ:MLECW – Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totaling 13,137 shares, an increase of 22.7% from the December 15th total of 10,703 shares. Based on an average daily volume of 38,322 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 38,322 shares, the short-interest ratio is presently 0.3 days.
Moolec Science Stock Down 12.2%
Shares of MLECW stock traded down $0.00 on Monday, hitting $0.01. 877,111 shares of the stock were exchanged, compared to its average volume of 861,719. Moolec Science has a fifty-two week low of $0.00 and a fifty-two week high of $0.05. The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.01.
About Moolec Science
Moolec Science is a biotechnology company focused on developing gene-edited livestock as living bioreactors to produce therapeutic proteins. The company leverages CRISPR/Cas9 and related gene-editing technologies to introduce human genes into the genome of pigs, enabling the secretion of complex human proteins in sow’s milk. By combining advanced genetic engineering with traditional livestock breeding, Moolec Science aims to address scalability and cost challenges associated with conventional biologics manufacturing.
The company’s pipeline centers on the production of large multimolecular proteins, including coagulation factors and antibody fragments, for rare diseases and life-threatening conditions.
Recommended Stories
- Five stocks we like better than Moolec Science
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
